Objective To provide an update on key safety metrics after transfusion of convalescent plasma
in hospitalized coronavirus 2019 (COVID-19) patients, having previously demonstrated …

BACKGROUND Convalescent plasma is the only antibody-based therapy currently available
for patients with coronavirus disease 2019 (COVID-19). It has robust historical precedence …

Background Convalescent plasma has been widely used to treat coronavirus disease 2019 (Covid-19)
under the presumption that such plasma contains potentially therapeutic …

Background The United States (US) Expanded Access Program (EAP) to coronavirus disease
2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of …

Successful therapeutics and vaccines for coronavirus disease 2019 (COVID-19) have
harnessed the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-…

Objective To examine the association of COVID-19 convalescent plasma transfusion with
mortality and the differences between subgroups in hospitalized patients with COVID-19. …

We describe here a novel protocol that sequentially combines venous followed by arterial
occlusions to determine muscle blood flow and O 2 uptake from a single measurement point …

Background The United States (US) Expanded Access Program (EAP) to COVID-19
convalescent plasma was initiated in response to the rapid spread of severe acute respiratory …

Background Previous studies have demonstrated that the near‐infrared spectroscopy venous
occlusion technique (NIRS‐VOT) provides a valid assessment of regional forearm muscle …

Due to the high vitamin D3 levels associated with improved prognosis (but not incidence) in
post-menopausal breast cancer patients with ER+ tumors, vitamin D3 supplementation has …